For instance, Alami et al. [18] found that recombinant human IGFBP-3 could inhibit the proliferation of lung cancer M-3 LL cells in a dose-dependent manner and could also significantly inhibit tumor growth in vivo. This evidence concerns the gene IGFBP3 and lung carcinoma.